Lead Share Agreement
List Biotherapeutics and Sacco System Announce Lead Share Agreement
List Biotherapeutics
PR-M03-24-03Mar 14, 2024
Microbiome
Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses
Stacy Burns-Guydish, Ph.D.
List Labs
PAO-10-23-CL-07-33Nov 01, 2023
Microbiome Therapeutic Innovation
Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future
Stacy Burns-Guydish, Ph.D.; Gary Henderson
List Labs
PAO-03-23-CL-08Apr 04, 2023
Microbiome-Based CDMO
Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing
Stacy Burns-Guydish, Ph.D.; Jonathan Yongwan Jo; Gary Henderson; Michael Kimble
List Labs
PAO-11-022-CL-13Dec 13, 2022
Live Biotherapeutic Products
Enabling the Commercialization of Microbiome Live Biotherapeutic Products with Fit-for-Purpose Cryopreservatives
Aaron B. Cowley, Ph.D.; Nicole O'Brien, Ph.D.
Arranta Bio
PAO-09-21-CL-11Sep 28, 2021
Live Biotherapeutic Products
Design Considerations for Live Biotherapeutic Product Facilities Working with Spore-Forming Bacteria
Aaron B. Cowley, Ph.D.; Judith Bodette; Brian Duffy
Arranta Bio
PAO-06-21-CL-10Jun 25, 2021
Live Biotherapeutic Products
Framing the Narrative on CMC Development for Microbiome Therapeutics
Aaron B. Cowley, Ph.D.; Melanie Cerullo; Jeff Heiser
Arranta Bio
PAO-06-21-CL-05Jun 14, 2021
Microbiome
Selecting a Microbiome CDMO Partner for the Long Term
Dave Stevens; Jason Rahal
Arranta Bio
PAP-Q2-20-CL-008Jul 01, 2020
Microbiome
Supporting Commercialization of Live Biotherapeutic Products for Microbiome-Based Therapies
Mark Bamforth
Arranta Bio
PAP-Q4-19-CL-009Dec 06, 2019